Presentation is loading. Please wait.

Presentation is loading. Please wait.

Beaver Dam Eye Study: Overall Participant Flow Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758.

Published byEmery Hicks Modified over 8 years ago

Similar presentations

Presentation on theme: "Beaver Dam Eye Study: Overall Participant Flow Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758."— Presentation transcript:

1 Beaver Dam Eye Study: Overall Participant Flow Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

2 Beaver Dam Eye Study: Flow of Participants From the Third Examination Who Were Eligible for Nuclear Cataract Analyses Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

3 Distribution and Age-Adjusted ORs for Each Cataract Type Based on Statin Use Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

4 Characteristics at the Third Examination (1998-2000) of Participants Who Developed Nuclear Cataract Compared With Those Who Did Not* Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

5 Five-Year Incidence of Nuclear Cataract Identified at Fourth Examination, Classified by Use of Statins at Third Examination, 1998-2000 Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

6 Incident Nuclear Cataract by Duration of Statin Use* Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758

Download ppt "Beaver Dam Eye Study: Overall Participant Flow Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758."

Similar presentations

Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165: 2264-2271.

Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165:
5.5.1 Plan of Operation 1 Guidelines for Implementation UPA Package 5, Module 5.

5.5.1 Plan of Operation 1 Guidelines for Implementation UPA Package 5, Module 5.
Flow diagram showing study population of Chinese patients with type 2 diabetes mellitus and reasons for exclusion Yang X et al. CMAJ 2008;179:427-37.

Flow diagram showing study population of Chinese patients with type 2 diabetes mellitus and reasons for exclusion Yang X et al. CMAJ 2008;179:
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Serum Lipids and Proliferative Diabetic Retinopathy Klein BEK, Myers CE, Howard.

Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Serum Lipids and Proliferative Diabetic Retinopathy Klein BEK, Myers CE, Howard.
Trial Identification, Inclusion, and Exclusion Krista M. Dale et al, JAMA. 2006; 295: 74-80.

Trial Identification, Inclusion, and Exclusion Krista M. Dale et al, JAMA. 2006; 295:
Weng TC, et al. J Clin Pharm Ther 2010;35:139-51.

Weng TC, et al. J Clin Pharm Ther 2010;35:
Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:299-308.

Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:
Flow of Participants Through the Trial David J. A. Jenkin et al. JAMA 2008;300:2742-53.

Flow of Participants Through the Trial David J. A. Jenkin et al. JAMA 2008;300:
Lars Sjöström et al N Engl J Med 2004; 351: 2683- 93 Characteristics of the Subjects at the Time of Matching and at the Time of the Inclusion Examination.

Lars Sjöström et al N Engl J Med 2004; 351: Characteristics of the Subjects at the Time of Matching and at the Time of the Inclusion Examination.
Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:2184- 92.

Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:
Solomon Tesfaye et al N Engl J Med 2005;352:341- 50 Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.
David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.

David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.
Characteristics of Large Prospective Randomized Controlled Statin Trials Included in the Present Analysis Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18.

Characteristics of Large Prospective Randomized Controlled Statin Trials Included in the Present Analysis Alawi A. Alsheikh-Ali, et al. JACC 2007;50:
Basic Characteristics of the Study Population Identified in Pennsylvania Medicare and Pharmaceutical Assistance Contract for the Elderly, 1994–2000 Soko.

Basic Characteristics of the Study Population Identified in Pennsylvania Medicare and Pharmaceutical Assistance Contract for the Elderly, 1994–2000 Soko.
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases by Porcia T. Bradford, Susan S. Devesa, William F. Anderson,

Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases by Porcia T. Bradford, Susan S. Devesa, William F. Anderson,
Study Flow Diagram Holvoet P, et al. JAMA 2008;299:2287-93 The Figure shows the selection of 1889 participants who did not have metabolic syndrome at year.

Study Flow Diagram Holvoet P, et al. JAMA 2008;299: The Figure shows the selection of 1889 participants who did not have metabolic syndrome at year.
Flow of Patients Through the Trial Nissen SE, et al. JAMA 2008;299:1561-73.

Flow of Patients Through the Trial Nissen SE, et al. JAMA 2008;299:
Flow Diagram of Identification of Randomized Trials for Inclusion Goran Bjelakovic, et al. JAMA. 2007;297:842-857.

Flow Diagram of Identification of Randomized Trials for Inclusion Goran Bjelakovic, et al. JAMA. 2007;297:
Delivery of care for adult patients with congenital heart disease in Europe: results from the Euro Heart Survey by Philip Moons, Peter Engelfriet, Harald.

Delivery of care for adult patients with congenital heart disease in Europe: results from the Euro Heart Survey by Philip Moons, Peter Engelfriet, Harald.
Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:306-313.

Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:

Similar presentations

Ads by Google